Key Insights

Highlights

Treatment Research

1 treatments under study, led by Arc

Research Leaders

8 sponsors active, led by Boston University

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting2
Not Yet Recruiting2

Clinical Trials (4)

Research Network

Common Treatments

  • Arc1

Active Sponsors

  • Boston University2
  • Bill and Melinda Gates Foundation2
  • University of Maryland, Baltimore1
  • Assiut University1
  • University of Alabama at Birmingham1

Top Investigators

Related Conditions

  • Poor Nutriyion Among Hiv Patients1

Activity Timeline